ERAP2 trims protein fragments before loading onto class I HLA. More trimming does not guarantee more useful display.
ERAP2 is an endoplasmic reticulum aminopeptidase involved in shaping peptides available for class I HLA. ERAP1 and ERAP2 have complementary substrate preferences in human biochemical experiments. Trimming can produce an appropriate peptide or remove a potentially useful one; abundance of the enzyme is not a universal measure of tumour targetability. Natural display, receptor recognition and treatment benefit remain separate questions.
In plain words · ERAP2 trims protein fragments before loading onto class I HLA. More trimming does not guarantee more useful display.
ERAP2 trims protein fragments before loading onto class I HLA. More trimming does not guarantee more useful display.
ERAP2 is an endoplasmic reticulum aminopeptidase involved in shaping peptides available for class I HLA. ERAP1 and ERAP2 have complementary substrate preferences in human biochemical experiments.
No product in this corpus aims at ERAP2 yet. Inhibitors are shaped to fit the enzyme's active site so the reaction the cancer relies on stops.
Sources: UniProt Q6P179: reviewed human ERAP2 protein (Reviewed human protein identity and function; primary gene name checked explicitly because TAP2 also matches a SEC14L3 synonym.); HGNC HGNC:29499 (Approved symbol, name and cross-references; raw HGNC REST record checked against reviewed human UniProt.)
ERAP2 is an endoplasmic reticulum aminopeptidase involved in shaping peptides available for class I HLA. ERAP1 and ERAP2 have complementary substrate preferences in human biochemical experiments.
Query for this target: (TITLE:"ERAP2" OR ABSTRACT:"ERAP2") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about ERAP2, not a curated reading list.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/